axel gräwingholt - what is interval cancer?
Published 2 years ago • 24 plays • Length 0:32Download video MP4
Download video MP3
Similar videos
-
0:36
axel gräwingholt - what is the clinical value of profound ai risk?
-
1:10
axel gräwingholt - what are the advantages of short-term risk assessment?
-
16:43
dr. gräwingholt - dbt and interval cancers presentation
-
0:30
axel gräwingholt - what are the advantages of short-term risk assessment?
-
1:29
axel gräwingholt | case study
-
1:38
axel gräwingholt, md discusses the future of breast cancer risk
-
1:18
axel gräwingholt - why do clinicians need a risk assessment tool?
-
0:32
axel gräwingholt - how does profound ai risk work?
-
1:14
axel grawingholt – short term risk patient communication
-
0:43
axel grawingholt, md - discover the power of profound ai for dbt
-
4:33
cbs | austin keye: innovative cancer detection with icad imaging
-
1:17
dr. gräwingholt case study with profound ai 2d mammography
-
6:30
dr. schilling full ecr study
-
0:43
mike klein - discover what's next for profound ai
-
0:46
alex gräwingholt, md – improved review for dbt
-
1:24
profound ai improves cancer detection rate across the board
-
3:51
case 3: dr. a case study of a 51 year old woman recalled from screening due to a suspicious finding
-
2:16
arquer diagnostics - the science of mcm5 based cancer detection